Mandatory T Tests Hit U.S. Troops 30+

Military dog tags on camouflage fabric with an American flag — MILITARY BOMBSHELL

The Pentagon just made testosterone checks mandatory for troops 30 and older, tying hormones to readiness and force health.

Story Snapshot

New policy orders annual testosterone screening in the military’s Periodic Health Assessment.
Leaders frame the move as health and performance optimization for readiness.
Medical groups and many doctors question mass screening benefits and warn of risks.
Treatment is voluntary; the order focuses on finding possible deficiency, not automatic therapy.

What the order says, and why it matters for readiness

The Pentagon issued a formal memorandum requiring all Active Duty and Reserve service members age thirty and older to be screened for testosterone deficiency during the annual Periodic Health Assessment. The order takes effect immediately and places the screening alongside other readiness checks that already happen each year.

Defense leaders link the move to “health and human performance optimization,” saying earlier detection can support strength, stamina, and long-term bone and metabolic health, which can influence deployability and fitness-to-fight.

The US Pentagon issued detailed guidance for a new, mandatory testosterone deficiency screening policy for active-duty and reserve service members age 30 and older, a follow-up ‌to Defense Secretary Pete Hegseth's July announcement https://t.co/uJh0d2pFAQ

— Reuters (@Reuters) September 3, 2026

The directive does not force treatment. It flags who should talk with a clinician and consider confirmatory testing if an initial result is low. Younger troops can seek testing through their providers but are not included in the mandate.

The Department of Defense will route the screening through the same Periodic Health Assessment systems that track immunizations, dental status, mental health review, and other readiness metrics, which helps commanders see unit medical status at a glance.

How screening actually works in real clinics

Testosterone levels vary by time of day, stress, sleep, weight, and illness. Good practice calls for a morning blood draw, often fasting, with a second test to confirm any low result before a diagnosis.

Doctors then match numbers to symptoms like low libido, erectile problems, fatigue, decreased muscle mass, or low bone density.

Many men with low readings have no symptoms, and many symptoms have other causes, from poor sleep to thyroid issues. That gray zone is where screening can generate extra tests and worry.

The Pentagon’s plan plugs into existing lab networks, but details matter: morning scheduling, repeat tests, and clear guidance to avoid overreacting to a single low value. Those steps reduce false positives and protect fertility plans for service members who still want children.

Testosterone therapy can lower sperm count and shrink testicular size, which requires counseling and alternatives such as medications that preserve fertility when appropriate. Clear rules will keep care patient-led, not metric-driven.

Supporters see preventive value; critics see thin evidence

Officials argue that identifying real deficiency can help the force over time by cutting fatigue, preserving muscle and bone, and improving recovery after injury.

That claim fits the military’s push to make the Periodic Health Assessment a true performance screen, not just a paperwork drill.

If the program stays targeted after initial labs, it could catch genuine endocrine problems earlier and guide lifestyle steps like weight loss, sleep fixes, and alcohol moderation before drugs enter the picture.

Clinical experts quoted by major outlets counter that broad screening of asymptomatic men has no proven readiness payoff and may spur needless treatment. Reuters reported most consulted physicians questioned blanket testing and warned of harm from overtreatment.

CBS News highlighted society guidance that recommends against general screening and noted cost and false positive risks.

The Department of Defense order itself stops short of mandatory therapy, which is prudent. That restraint respects evidence-based care while the military measures outcomes in the real world.

What common-sense guardrails should the Pentagon adopt now

Require two morning tests before any diagnosis. Tie treatment to clear symptoms and shared decision-making. Track fertility counseling before therapy and offer sperm preservation options where needed.

Publish simple, troop-facing guides so service members know what a low result means and what it does not. Audit units for coercion signals, like tying promotions or special duty to hormone levels. Report readiness outcomes in plain numbers so Congress and the ranks can judge the program’s value.

Screening can support those aims if it stays tight, transparent, and clinician-led. The memo sets a bold intent; the next step is proof.

If readiness, injury recovery, and retention improve without spikes in overtreatment or fertility harm, the program earns its place. If not, scale it back. That is how a serious force tests ideas: measure, compare, and adjust rather than chase headlines.